Ayrshire Capital Management’s Zimmer Biomet ZBH Stock Holding History

Ayrshire Capital Management’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-25,676	Closed	-$4.01M	–	54
2021 Q2	$4.01M	Buy	25,676 +1,326	+5%	+$215K	2.26%	24
2021 Q1	$3.78M	Buy	24,350 +1,088	+5%	+$169K	2.32%	22
2020 Q4	$3.48M	Buy	23,262 +1,117	+5%	+$158K	2.25%	22
2020 Q3	$2.93M	Buy	22,145 +1,843	+9%	+$241K	2.15%	22
2020 Q2	$2.35M	Buy	20,302 +804	+4%	+$92.6K	1.97%	23
2020 Q1	$1.91M	Buy	19,498 +1,526	+8%	+$200K	1.93%	25
2019 Q4	$2.61M	Buy	+17,972	New	+$2.48M	2.16%	22

Other funds holding ZBH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Ayrshire Capital Management's ZBH Position: Q3 2021 in Review

Ayrshire Capital Management sold out of Zimmer Biomet (ZBH) in Q3 2021, closing a stake of 25,676 shares — an estimated $4.01M sold.

Ayrshire Capital Management first reported a position in ZBH in Q4 2019 and held it in 7 quarters. The position peaked at $4.01M in Q2 2021. 982 funds tracked by Wall St. Rank hold ZBH as of Q3 2021.

Ayrshire Capital Management reported no remaining Zimmer Biomet position as of Q3 2021 after selling out during the quarter.
Ayrshire Capital Management sold 25,676 Zimmer Biomet shares in Q3 2021, an estimated $4.01M.
Ayrshire Capital Management first reported a position in Zimmer Biomet in Q4 2019 and held it in 7 quarters.
Ayrshire Capital Management's Zimmer Biomet position peaked at $4.01M in Q2 2021.
982 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2021.

Based on Ayrshire Capital Management's 13F filing for Q3 2021, filed 12 Oct 2021.